Literature DB >> 26362115

Impact of Ternary Solvent System in Stability-Indicating Assay Method of Bambuterol: Design of Experiments Approach.

A Abiramasundari1, Amita Joshi2, Rahul Joshi3, Dhaivat Pandya3, Jayesh Sharma3, V Sudarsanam3, Kamala K Vasu4.   

Abstract

High-performance liquid chromatography method for anti-asthmatic β2-agonist drug bambuterol, its process-related impurities and its major degradation products was developed and validated using quality by design concept. A 3(3) full factorial design was employed to study the effect of three independent factors, namely, ratio of organic modifiers in mobile phase, pH of the buffer and flow rate of the mobile phase. The responses considered were retention time of the last peak and resolution of poorly separated peaks (drug and PR-4 and drug and DP-3). The optimum conditions for separation were determined with the aid of design of experiments. The optimized ternary solvent composition was a mixture of 10 mM ammonium acetate buffer (pH 6.0), methanol and acetonitrile in the ratio of 90:5: 5 (v/v/v) in solvent reservoir A and 10:45:45 (v/v/v) in solvent reservoir B. The separation of the analytes was achieved by using a gradient method. The predictability criteria of the optimized method demonstrated good correlation between observed and predicted response. The method was validated for specificity, linearity, accuracy, precision and robustness in compliance with the International Conference on Harmonization guidelines Q2R1.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26362115     DOI: 10.1093/chromsci/bmv137

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  1 in total

1.  Quick simultaneous analysis of bambuterol and montelukast based on synchronous spectrofluorimetric technique.

Authors:  Rania El Gamal; Samah Abo El Abass; Heba M Elmansi
Journal:  R Soc Open Sci       Date:  2020-12-09       Impact factor: 2.963

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.